Long-term Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion (from the CREDO-Kyoto Registry Cohort-2)
Overview
Authors
Affiliations
Despite improving success rate of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) lesions, the clinical benefit of recanalization of CTO is still a matter of debate. Of 13,087 patients who underwent PCI in the CREDO-Kyoto registry cohort-2, 1,524 patients received PCI for CTO (CTO-PCI). Clinical outcomes were compared between 1,192 patients with successful CTO-PCI and 332 patients with failed CTO-PCI. In-hospital death tended to occur less frequently in the successful CTO-PCI group than in the failed CTO-PCI group (1.4% vs 3.0%, p = 0.053). Through 3-year follow-up, the cumulative incidence of all-cause death was not significantly different between the successful and failed CTO-PCI groups (9.0% vs 13.1%, p = 0.18), whereas the cumulative incidence of cardiac death was significantly less in the successful CTO-PCI group than in the failed CTO-PCI group (4.5% vs 8.4%, p = 0.03). However, after adjusting confounders, successful CTO-PCI was associated with lesser risk for neither all-cause death (hazard ratio 0.93, 95% confidence interval 0.64 to 1.37, p = 0.69) nor cardiac death (hazard ratio 0.71, 95% confidence interval 0.44 to 1.16, p = 0.16). The cumulative incidence of coronary artery bypass grafting (CABG) was remarkably less in patients with successful PCI compared with those with failed PCI (1.8% vs 19.6%, p <0.0001). In conclusion, successful CTO-PCI compared with failed PCI was not associated with lesser risk for 3-year mortality. However, successful CTO-PCI was associated with significantly less subsequent CABG.
Will M, Schwarz K, Aufhauser S, Leibundgut G, Schmidt E, Mayer D Front Cardiovasc Med. 2024; 11:1447829.
PMID: 39399513 PMC: 11470476. DOI: 10.3389/fcvm.2024.1447829.
Zhong Z, Zhao L, Chen K, Xia S Cardiol Res Pract. 2022; 2022:4170060.
PMID: 35342644 PMC: 8947918. DOI: 10.1155/2022/4170060.
Guo L, Meng S, Lv H, Zhong L, Wu J, Ding H Front Cardiovasc Med. 2021; 8:654730.
PMID: 33959643 PMC: 8093409. DOI: 10.3389/fcvm.2021.654730.
Malik A, Spertus J, Grantham J, Peri-Okonny P, Gosch K, Sapontis J Am J Cardiol. 2020; 125(7):1046-1053.
PMID: 31955832 PMC: 7064413. DOI: 10.1016/j.amjcard.2019.12.045.
Guelker J, Bansemir L, Ott R, Rock T, Guelker R, Shin D J Tehran Heart Cent. 2019; 14(2):47-52.
PMID: 31723345 PMC: 6842020.